Association of Chemotherapy-Induced Peripheral Neuropathy with Diet Quality Among Post-Treatment Cancer Survivors

References

• Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–2470. doi: 10.1016/j.pain.2014.09.020
   PubMed Web of Science ®Google Scholar
• Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S, Mooney K. The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol. 2016;73(7):860–866. doi: 10.1001/jamaneurol.2016.0383
   PubMed Web of Science ®Google Scholar
• Beijers A, Mols F, Dercksen W, Driessen C, Vreugdenhil G. Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy. J Community Support Oncol. 2014;12(11):401–406. doi: 10.12788/jcso.0086
   Google Scholar
• Zanville NR, Nudelman KNH, Smith DJ, Von Ah D, McDonald BC, Champion VL, Saykin AJ. Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment. Support Care Cancer. 2016;24(11):4779–4789. doi: 10.1007/s00520-016-3329-5
   PubMed Web of Science ®Google Scholar
• Knoerl R, Wallar J, Fox E, Hong F, Salehi E, McCleary N, Ligibel JA, Reyes K, Berry DL. Exploring clinicians’ perspectives of barriers to chemotherapy-induced peripheral neuropathy assessment and management in oncology practice: a qualitative analysis of semi-structured ­interviews. Cancer Nurs. 2023;46(2):103–110. doi: 10.1097/NCC.0000000000001082
   PubMed Web of Science ®Google Scholar
• Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, et al. integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2022;40(34):3998–4024.
   PubMed Web of Science ®Google Scholar
• El Soury M, Fornasari BE, Carta G, Zen F, Haastert-Talini K, Ronchi G. The role of dietary nutrients in peripheral nerve regeneration. Int J Mol Sci. 2021;22(14):7417. doi: 10.3390/ijms22147417
   Web of Science ®Google Scholar
• Blanchard CM, Courneya KS, Stein K, American Cancer Society’s SCS-II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–2204. doi: 10.1200/JCO.2007.14.6217
   PubMed Web of Science ®Google Scholar
• Lee E, Zhu J, Velazquez J, Bernardo R, Garcia J, Rovito M, Hines RB. Evaluation of diet quality among American adult cancer survivors: results from 2005-2016 National Health and Nutrition Examination Survey. J Acad Nutr Diet. 2021;121(2):217–232. doi: 10.1016/j.jand.2020.08.086
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325–3348. doi: 10.1200/JCO.20.01399
   PubMed Web of Science ®Google Scholar
• Tofthagen C, Tanay M, Perlman A, Starr J, Advani P, Sheffield K, Brigham T. A systematic review of nutritional lab correlates with chemotherapy induced peripheral neuropathy. J Clin Med. 2022;11(2):355. https://doi.org/10.3390/jcm11020355.
   PubMed Web of Science ®Google Scholar
• Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, et al. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221). Breast Cancer Res. 2018;20(1):146. doi: 10.1186/s13058-018-1077-9
   PubMedGoogle Scholar
• Schakel SF, Buzzard IM, Gebhardt SE. Procedures for estimating nutrient values for food composition databases. J Food Compos Anal. 1997;10(2):102–114.
   Google Scholar
• Schakel SF. Maintaining a nutrient database in a changing marketplace: keeping pace with changing food products—a research perspective. J Food Compos Anal. 2001;14(3):315–322.
   Web of Science ®Google Scholar
• Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc. 1988;88(10):1268–1271. doi: 10.1016/S0002-8223(21)07997-9
   PubMedGoogle Scholar
• Kristal AR, Kolar AS, Fisher JL, Plascak JJ, Stumbo PJ, Weiss R, Paskett ED. Evaluation of web-based, self-administered, graphical food frequency questionnaire. J Acad Nutr Diet. 2014;114(4):613–621. doi: 10.1016/j.jand.2013.11.017
   PubMed Web of Science ®Google Scholar
• Guenther PM, Kirkpatrick SI, Reedy J, Krebs-Smith SM, Buckman DW, Dodd KW, et al. The Healthy Eating Index-2010 is a valid and reliable measure of diet quality according to the 2010 Dietary Guidelines for Americans. J Nutr. 2014;144(3):399–407.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Agriculture Food and Nutrition Service. How the HEI is scored [Internet]. 2023. https://www.fns.usda.gov/cnpp/how-hei-scored (Accessed 15 February, 2024).
   Google Scholar
• United States Department of Agriculture. How many calories are in one gram of fat, carbohydrate, or protein? | Food and Nutrition Information Center| NAL | USDA [Internet]. 2022 [cited 2022 May 31]. https://www.nal.usda.gov/legacy/fnic/how-many-calories-are-one-gram-fat-carbohydrate-or-protein (Accessed 15 February, 2024).
   Google Scholar
• Zick SM, Murphy SL, Colacino J. Association of chronic spinal pain with diet quality. Pain Rep. 2020;5(5):e837.
   PubMedGoogle Scholar
• Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O’Mara AM, et al. Validity and reliability of the US National Cancer Institute’s patient-reported ­outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol. 2015;1(8):1051–1059. doi: 10.1001/jamaoncol.2015.2639
   PubMed Web of Science ®Google Scholar
• Reeve BB, McFatrich M, Pinheiro LC, Freyer DR, Basch EM, Baker JN, et al. Cognitive interview-based validation of the patient-reported outcomes version of the common terminology criteria for adverse events in adolescents with cancer. J Pain Symptom Manage. 2017;53(4):759–766.
   PubMed Web of Science ®Google Scholar
• Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O’Mara A, et al. Cognitive interviewing of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Qual Life Res. 2014;23(1):257–269. doi: 10.1007/s11136-013-0470-1
   PubMed Web of Science ®Google Scholar
• Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):244.
   Google Scholar
• Bennett AV, Dueck AC, Mitchell SA, Mendoza TR, Reeve BB, Atkinson TM, Castro KM, Denicoff A, Rogak LJ, Harness JK, et al. Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Health Qual Life Outcomes. 2016;14(1):24. doi: 10.1186/s12955-016-0426-6
   PubMedGoogle Scholar
• Knoerl R, Gray E, Stricker C, Mitchell SA, Kippe K, Smith G, Dudley WN, Lavoie Smith EM. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2017;25(11):3437–3446. doi: 10.1007/s00520-017-3764-y
   PubMed Web of Science ®Google Scholar
• Knoerl R, Mazzola E, Mitchell SA, Hong F, Salehi E, McCleary N, Ligibel JA, Reyes K, Berry DL. Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors. J Patient Rep Outcomes. 2021;5(1):101. doi: 10.1186/s41687-021-00377-z
   PubMedGoogle Scholar
• McCrary JM, Goldstein D, Trinh T, Timmins HC, Li T, Friedlander M, et al. Optimising clinical screening for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage. 2019;58(6):1023–1032. doi:10.1016/j.jpainsymman.2019.07.021
   PubMed Web of Science ®Google Scholar
• Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41(8):1135–1139. doi: 10.1016/j.ejca.2005.02.012
   PubMed Web of Science ®Google Scholar
• Smith EML, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res. 2013;22(10):2787–2799. doi: 10.1007/s11136-013-0379-8
   PubMed Web of Science ®Google Scholar
• Gionet NJ, Godin G. Self-reported exercise behavior of employees: a validity study. J Occup Med. 1989;31(12):969–973.
   PubMedGoogle Scholar
• Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–146.
   PubMedGoogle Scholar
• Godin G. The Godin-Shephard Leisure-Time Physical Activity Questionnaire. Heal Fit J Canada. 2011;4(1):18–22. https://doi.org/10.14288/hfjc.v4i1.82.
   Google Scholar
• Amireault S, Godin G, Lacombe J, Sabiston CM. Validation of the Godin-Shephard Leisure-Time Physical Activity Questionnaire classification coding system using accelerometer assessment among breast cancer survivors. J Cancer Surviv. 2015;9(3):532–540. doi: 10.1007/s11764-015-0430-6
   PubMed Web of Science ®Google Scholar
• Amireault S, Godin G, Lacombe J, Sabiston CM. The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review. BMC Med Res Methodol. 2015;15(1):60. doi: 10.1186/s12874-015-0045-7
   PubMedGoogle Scholar
• StataCorp. Stata Statistical Software: release 18. College Station (TX): StataCorp LLC; 2023.
   Google Scholar
• Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond “p < 0.05.” Am Stat. 2019;73(sup1):1–19.
   Web of Science ®Google Scholar
• Lee E, Hines R, Schulz V, Rovito M, Garcia J. Diet quality in a nationally representative sample of American adult cancer survivors (P05-028-19). Curr Dev Nutr. 2019;3:nzz030.P05-028-19.
   Google Scholar
• Kenkhuis M-F, Mols F, van Roekel EH, Breedveld-Peters JJL, Breukink S, Janssen-Heijnen M, Keulen E, van Duijnhoven FJ, Weijenberg MP, Bours M, et al. Longitudinal associations of fast foods, red and processed meat, alcohol and sugar-sweetened drinks with quality of life and symptoms in colorectal cancer survivors up to 24 months post-treatment. Br J Nutr. 2023;130(1):114–126. doi: 10.1017/S0007114522003051
   PubMed Web of Science ®Google Scholar
• O’Loughlin I, Newton-John TRO. ‘Dis-comfort eating’: An investigation into the use of food as a coping strategy for the management of chronic pain. Appetite. 2019;140:288–297. doi: 10.1016/j.appet.2019.05.027
   PubMed Web of Science ®Google Scholar
• De Freitas RL, Kübler JML, Elias-Filho DH, Coimbra NC. Antinociception induced by acute oral administration of sweet substance in young and adult rodents: the role of endogenous opioid peptides chemical ­mediators and μ1-opioid receptors. Pharmacol Biochem Behav. 2012;101(2):265–270.
   PubMed Web of Science ®Google Scholar
• Park SB, Cetinkaya-Fisgin A, Argyriou AA, Höke A, Cavaletti G, Alberti P. Review: axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence. J Neurol Neurosurg Psychiatry. 2023;94(11):962–972. doi: 10.1136/jnnp-2021-328323
   PubMed Web of Science ®Google Scholar
• Kleckner IR, Jusko TA, Culakova E, Chung K, Kleckner AS, Asare M, Inglis JE, Loh KP, Peppone LJ, Miller J, et al. Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy. Breast Cancer Res Treat. 2021;189(2):521–532. doi: 10.1007/s10549-021-06304-6
   PubMed Web of Science ®Google Scholar
• Grosso G, Laudisio D, Frias-Toral E, Barrea L, Muscogiuri G, Savastano S, Colao A on behalf of the Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) Group. Anti-inflammatory nutrients and obesity-associated metabolic-inflammation: state of the art and future direction. Nutrients. 2022;14(6):1137. doi: 10.3390/nu14061137
   Web of Science ®Google Scholar
• Inglis JE, Lin P-J, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ. Nutritional interventions for treating cancer-related fatigue: a qualitative review. Nutr Cancer. 2019;71(1):21–40.
   PubMed Web of Science ®Google Scholar
• Weinhold KR, Light S, Bittoni AM, Zick S, Orchard TS. A remote whole food dietary intervention to reduce fatigue and improve diet quality in lymphoma survivors: results of a feasibility pilot study. Nutr Cancer. 2023;75(3):937–947. doi: 10.1080/01635581.2023.2173259
   PubMed Web of Science ®Google Scholar
• George MA, Lustberg MB, Orchard TS. Psychoneurological symptom cluster in breast cancer: the role of inflammation and diet. Breast Cancer Res Treat. 2020;184(1):1–9. doi: 10.1007/s10549-020-05808-x
   PubMed Web of Science ®Google Scholar
• Kenkhuis M-F, van Duijnhoven FJB, van Roekel EH, Breedveld-Peters JJL, Breukink SO, Janssen-Heijnen ML, Keulen ETP, Mols F, Weijenberg MP, Bours MJL, et al. Longitudinal associations of fiber, vegetable, and fruit intake with quality of life and fatigue in colorectal cancer survivors up to 24 months posttreatment. Am J Clin Nutr. 2022;115(3):822–832. doi: 10.1093/ajcn/nqab360
   PubMed Web of Science ®Google Scholar
• Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, Kushi LH. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study. J Natl Cancer Inst. 2017;109(2):djw206. doi: 10.1093/jnci/djw206
   PubMedGoogle Scholar
• Knoerl R, Berry D, Meyerhardt JA, Reyes K, Salehi E, Thornton K, Gewandter JS. Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis. Support Care Cancer. 2022;30(12):9963–9973. doi: 10.1007/s00520-022-07447-y
   PubMed Web of Science ®Google Scholar